Ramsay Générale de Santé's 2022 Universal Registration Document was filed with the Autorité des marchés financiers (AMF) in ESEF (European Single Electronic Format) on Friday 28 October 2022, under number D.22-0786.
The solid performance of the Nordic countries has led to an improvement in the results of the Ramsay Santé group, despite the persistent challenges of high inflation, a shortage of nursing and clinical staff and the ongoing pandemic, in which Ramsay Santé has continued to play a leading role in Europe.
After renegotiating its syndicated debt in April 2021 with a TLB linked to its ESG performance and issuing a Euro PP in December 2021, Ramsay Santé is pursuing its refinancing and sustainable commitment dynamic.
Unaudited turnover for the 9 months period ending 31 March 2022 amounted to €3,141.7m, up 6.7% compared to the same period of the previous year.
Ramsay Santé pursues its sustainable commitments with the launch of its third financial instrument linked to sustainable development goals.
A continued positive development in the Nordics but a more complicated than expected recovery in business in France due to a fourth wave of Covid, and staff challenges.
Confirmation of data published at the end of August 2021
It is now expected that the final consolidated financial statements for the year ended June 2021 will be approved by the Board of Directors at its meeting on October 20, 2021
Strong financial results demonstrating the relevance of our strategic move as a global health provider in Continental Europe, in a Covid context where Ramsay Santé has kept on playing a critical role to take care of patients.
